Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Veritas In Silico Inc. ( (JP:130A) ) has provided an announcement.
Veritas In Silico Inc. reported a steep year-on-year decline in business revenue to ¥91 million for the fiscal year ended December 31, 2025, alongside a widened net loss of ¥425 million and negative earnings per share of ¥65.62. Total assets fell to ¥1,884 million and the equity ratio eased to 94.6%, while the company continued its no-dividend policy and used ¥299 million in operating cash, partly offset by ¥451 million in investing inflows, resulting in year-end cash and equivalents of ¥325 million.
For fiscal 2026, the company forecasts a 24.2% rebound in business revenue to ¥113 million but expects operating and net losses to deepen further, with projected net loss of ¥567 million and earnings per share of ¥87.44 in the red. The guidance underscores that Veritas In Silico remains in an investment and loss-making phase, prioritizing capital strength and liquidity management over shareholder payouts as it pursues its business development plans.
More about Veritas In Silico Inc.
Veritas In Silico Inc. is a Tokyo Stock Exchange–listed company operating under Japanese GAAP, focused on research-driven activities rather than large-scale commercial revenue at this stage. The company maintains a high equity ratio, indicating a relatively strong capital base despite ongoing net losses and modest business revenue levels.
Average Trading Volume: 222,000
Technical Sentiment Signal: Sell
Current Market Cap: Yen3.17B
For an in-depth examination of 130A stock, go to TipRanks’ Overview page.